122 related articles for article (PubMed ID: 8388322)
1. Modulation of T cell proliferation by stimulation of the beta-adrenergic receptor: lack of correlation between inhibition of T cell proliferation and cAMP accumulation.
Bartik MM; Brooks WH; Roszman TL
Cell Immunol; 1993 May; 148(2):408-21. PubMed ID: 8388322
[TBL] [Abstract][Full Text] [Related]
2. Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells.
Bartik MM; Bauman GP; Brooks WH; Roszman TL
Cell Immunol; 1994 Oct; 158(1):116-30. PubMed ID: 8087859
[TBL] [Abstract][Full Text] [Related]
3. Induction of cAMP-dependent protein kinase (PKA) activity in T cells after stimulation of the prostaglandin E2 or the beta-adrenergic receptors: relationship between PKA activity and inhibition of anti-CD3 monoclonal antibody-induced T cell proliferation.
Bauman GP; Bartik MM; Brooks WH; Roszman TL
Cell Immunol; 1994 Oct; 158(1):182-94. PubMed ID: 8087864
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of anti-CD3 monoclonal antibody-induced T-cell proliferation by dexamethasone, isoproterenol, or prostaglandin E2 either alone or in combination.
Elliott L; Brooks W; Roszman T
Cell Mol Neurobiol; 1992 Oct; 12(5):411-27. PubMed ID: 1334806
[TBL] [Abstract][Full Text] [Related]
5. Delineation of the mechanism of inhibition of human T cell activation by PGE2.
Minakuchi R; Wacholtz MC; Davis LS; Lipsky PE
J Immunol; 1990 Oct; 145(8):2616-25. PubMed ID: 1976699
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone and prostaglandin E2 modulate T-cell receptor signaling through a cAMP-independent mechanism.
Elliott LH; Levay AK; Sparks B; Miller M; Roszman TL
Cell Immunol; 1996 Apr; 169(1):117-24. PubMed ID: 8612284
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression.
Chouaib S; Welte K; Mertelsmann R; Dupont B
J Immunol; 1985 Aug; 135(2):1172-9. PubMed ID: 2989362
[TBL] [Abstract][Full Text] [Related]
8. beta-Agonist enhances type 2 T-cell survival and accumulation.
Loza MJ; Peters SP; Foster S; Khan IU; Penn RB
J Allergy Clin Immunol; 2007 Jan; 119(1):235-44. PubMed ID: 17208607
[TBL] [Abstract][Full Text] [Related]
9. Differential responses of invariant V alpha 24J alpha Q T cells and MHC class II-restricted CD4+ T cells to dexamethasone.
Milner JD; Kent SC; Ashley TA; Wilson SB; Strominger JL; Hafler DA
J Immunol; 1999 Sep; 163(5):2522-9. PubMed ID: 10452989
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to CD44 trigger effector functions of human T cell clones.
Galandrini R; Albi N; Tripodi G; Zarcone D; Terenzi A; Moretta A; Grossi CE; Velardi A
J Immunol; 1993 May; 150(10):4225-35. PubMed ID: 8097750
[TBL] [Abstract][Full Text] [Related]
11. Regulation of beta-agonist- and prostaglandin E2-mediated adenylyl cyclase activity in human airway epithelial cells.
Penn RB; Kelsen SG; Benovic JL
Am J Respir Cell Mol Biol; 1994 Oct; 11(4):496-505. PubMed ID: 7917318
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of beta-adrenergic-induced cAMP accumulation in activated T-cells.
Carlson SL; Trauth K; Brooks WH; Roszman TL
J Cell Physiol; 1994 Oct; 161(1):39-48. PubMed ID: 7929606
[TBL] [Abstract][Full Text] [Related]
13. Macrophage inflammatory protein-1 alpha rapidly modulates its receptors and inhibits the anti-CD3 mAb-mediated proliferation of T lymphocytes.
Zhou Z; Kim YJ; Pollok K; Hurtado J; Lee JK; Broxmeyer HE; Kwon BS
J Immunol; 1993 Oct; 151(8):4333-41. PubMed ID: 8409405
[TBL] [Abstract][Full Text] [Related]
14. cAMP inhibits the OKT3-induced increase in cytoplasmic free calcium in the Jurkat T cell line: the degree of inhibition correlates inversely with the amount of CD3 binding ligand used.
Papadogiannakis N; Nordström TE; Andersson LC; Wolff CH
Eur J Immunol; 1989 Oct; 19(10):1953-6. PubMed ID: 2555197
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of mouse B-cell activation by beta-adrenoceptor stimulation depending on type of mitogens.
Li YS; Kouassi E; Revillard JP
Immunology; 1990 Mar; 69(3):367-72. PubMed ID: 2155873
[TBL] [Abstract][Full Text] [Related]
16. Different effect of prostaglandin E2 on B-cell activation by two distinct B-cell differentiation factors, B151-TRF1/IL-5 and B151-TRF2: selective inhibition of B151-TRF2-induced antibody response through increases in intracellular cyclic AMP levels.
Ishihara K; Ono S; Takahama Y; Hirayama F; Hirano H; Itoh K; Dobashi K; Murakami S; Katoh Y; Yamaguchi M
Immunology; 1989 Oct; 68(2):154-62. PubMed ID: 2553585
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 inhibits T cell-dependent Ig secretion by neonatal but not adult lymphocytes.
Splawski JB; Lipsky PE
J Immunol; 1994 Jun; 152(11):5259-67. PubMed ID: 7514634
[TBL] [Abstract][Full Text] [Related]
18. Comparison of cyclic AMP accumulation and morphological changes induced by beta-adrenergic stimulation of cultured vascular smooth muscle cells and fibroblasts.
Nabika T; Velletri PA; Igawa T; Yamori Y; Lovenberg W
Blood Vessels; 1985; 22(1):47-56. PubMed ID: 2857102
[TBL] [Abstract][Full Text] [Related]
19. Deficient CD4+ T cell proliferation in the class 1 MHC-restricted 2C TCR-transgenic mouse.
Chen FL; Kung JT
J Immunol; 1996 Mar; 156(6):2036-44. PubMed ID: 8690890
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 inhibits the activation of cloned T cell hybridomas.
Makoul GT; Robinson DR; Bhalla AK; Glimcher LH
J Immunol; 1985 Apr; 134(4):2645-50. PubMed ID: 2857750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
